These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 1922173)
1. Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. Lange DJ; Rubin M; Greene PE; Kang UJ; Moskowitz CB; Brin MF; Lovelace RE; Fahn S Muscle Nerve; 1991 Jul; 14(7):672-5. PubMed ID: 1922173 [TBL] [Abstract][Full Text] [Related]
2. Time course of distant effects of local injections of botulinum toxin. Garner CG; Straube A; Witt TN; Gasser T; Oertel WH Mov Disord; 1993; 8(1):33-7. PubMed ID: 8380486 [TBL] [Abstract][Full Text] [Related]
3. [Remote effects of local injection of botulinum toxin type A]. Wan X; Tang X; Cui L Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct; 21(5):362-7. PubMed ID: 12567434 [TBL] [Abstract][Full Text] [Related]
5. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke. Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937 [TBL] [Abstract][Full Text] [Related]
6. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis]. Wissel J; Entner T Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048 [TBL] [Abstract][Full Text] [Related]
7. Age-related botulinum toxin effects on muscle fiber conduction velocity in non-injected muscles. Lange F; van Weerden TW; van der Hoeven JH Clin Neurophysiol; 2007 Nov; 118(11):2398-403. PubMed ID: 17897878 [TBL] [Abstract][Full Text] [Related]
8. Distant effects of local injection of botulinum toxin. Lange DJ; Brin MF; Warner CL; Fahn S; Lovelace RE Muscle Nerve; 1987; 10(6):552-5. PubMed ID: 3455658 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Botox with a Chinese type A botulinum toxin. Tang X; Wan X Chin Med J (Engl); 2000 Sep; 113(9):794-8. PubMed ID: 11776072 [TBL] [Abstract][Full Text] [Related]
10. Physiological effects of botulinum toxin in spasticity. Gracies JM Mov Disord; 2004 Mar; 19 Suppl 8():S120-8. PubMed ID: 15027064 [TBL] [Abstract][Full Text] [Related]
11. The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials. Lew MF; Brashear A; Factor S Neurology; 2000; 55(12 Suppl 5):S29-35. PubMed ID: 11188982 [TBL] [Abstract][Full Text] [Related]
12. Quantitative electromyographical changes in cervical dystonia after treatment with botulinum toxin. Fuglsang-Frederiksen A; Ostergaard L; Sjö O; Werdelin L; Winkel H Electromyogr Clin Neurophysiol; 1998 Mar; 38(2):75-9. PubMed ID: 9553744 [TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia. Tassorelli C; Mancini F; Balloni L; Pacchetti C; Sandrini G; Nappi G; Martignoni E Mov Disord; 2006 Dec; 21(12):2240-3. PubMed ID: 17029278 [TBL] [Abstract][Full Text] [Related]
15. Botulinum neurotoxin-A does not spread to distant muscles after intragastric injection: A double-blind single-fiber electromyography study. Osio M; Mailland E; Muscia F; Nascimbene C; Vanotti A; Bana C; Corsi F; Foschi D; Mariani C Muscle Nerve; 2010 Aug; 42(2):165-9. PubMed ID: 20564593 [TBL] [Abstract][Full Text] [Related]
16. [The clinical usefulness of botulinum toxin type A for spasmodic torticollis and facial spasm]. Mezaki T; Kaji R; Kimura J; Osame M; Mizuno Y; Hirayama K; Maruyama S; Iwata M; Kanazawa I; Kinoshita M No To Shinkei; 1995 Aug; 47(8):749-54. PubMed ID: 7546919 [TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism. Bonanni L; Thomas A; Varanese S; Scorrano V; Onofrj M Mov Disord; 2007 Oct; 22(14):2097-103. PubMed ID: 17685467 [TBL] [Abstract][Full Text] [Related]
18. Treatment of idiopathic spasmodic torticollis with botulinum toxin A: a double-blind study on twenty-three patients. Lorentz IT; Subramaniam SS; Yiannikas C Mov Disord; 1991; 6(2):145-50. PubMed ID: 2057005 [TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD; Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567 [TBL] [Abstract][Full Text] [Related]